ERT Demonstrates Latest eClinical Innovations That Help Sponsors, CROs And Sites Conduct Better Pati
Novel product advancements to be showcased at Drug Information Association Annual Meeting
PHILADELPHIA – June 15, 2015 ––ERT, a leading global provider of high-quality patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions, today announced a number of product updates it will demonstrate at the Drug Information Association (DIA) Annual Meeting in Washington, DC June 14-17, 2015.
DIA Annual Meeting attendees can visit ERT’s Innovation Lab booth #2000 and expanded booth #2025 for live, interactive demonstrations of advancements to its line of eClinical trial solutions, including:
• Wireless ECG / eCOA Tablet Integration: Integrating ECG data wirelessly with electronic clinical outcome assessment (eCOA) data reduces site burden while increasing data integrity. ERT will demonstrate how this advanced wireless solution reduces investigator site burden and improves clinical data quality.
• ERT Insights Cloud™: A first-in-class solution, ERT’s agile and adaptive Insights Cloud delivers unparalleled visibility and control across all of the disparate systems and diverse teams involved in global clinical trials, providing end-to-end visibility across data sources and putting clinical trial intelligence at the sponsor’s fingertips.
• Site Selection Analytics: This latest addition to the ERT Insights Cloud delivers data on over 40,000 sites and millions of trial endpoints to provide sponsors and CROs with an industry-unique set of data to complement their investigative site evaluation process.
• MasterScope 2: ERT’s comprehensive, diagnostic platform for spirometry, ECG, and home monitoring meets the data collection and processing needs of worldwide clinical trial sponsors in the development of medical treatments for respiratory conditions.
•Wireless Biosensor / eCOA System Integration: ERT will demonstrate a proof of concept integration of near real-time, continuous, clinical-grade biometric measurements captured on a wearable patch biosensor into ERT’s eCOA System.
•Patient Connect Engagement App: See a demonstration of how ERT helps sponsors retain patients by providing education, plain language, visit information, and shared data and allows patient to connect with the site and share information with family members.
• Rater Training: Learn how Rater Training is used within clinical trials to improve the consistency of subjective data collected from interviewers – and has been proven to reduce rater errors and standardize scale administration.
• eCOA App – Get hands on experience and demo the leading eCOA app on various smartphone and tablets including a mega Smartphone pad.
Information on these and many other novel product developments that will be showcased during the DIA Annual meeting can be found at http://www.ert.com/dia-annual-meeting/. “DIA Annual Meeting attendees will not want to miss the exciting developments being presented this week,” said Scott Dixon, Vice President, Marketing and Corporate Strategy at ERT. “By continually advancing our line of eClinical trial solutions, ERT is truly innovating better health and helping pharmaceutical companies and CROs meet their clinical objectives more efficiently and reliably not only today, but looking toward the trial of the future.”
For more information, visit http://ert.com/dia-annual-meeting/.
About ERT
ERT (http://www.ert.com) is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the efficiency of the clinical development process throughout the product lifecycle. ERT delivers the most widely deployed solutions in centralized Cardiac Safety, Respiratory, Suicide Risk Assessment, electronic Clinical Outcome Assessments (eCOA) – which includes patient-, clinician-, observer- and performance-reported outcomes – and cloud-based analytics and performance metrics. By efficiently integrating these solutions through a system built upon a scientific and regulatory foundation, ERT collects, analyzes and delivers safety and efficacy data critical to the approval, labeling and reimbursement of pharmaceutical products. ERT is a global organization with headquarters in Philadelphia, PA and offices throughout the U.S., U.K., Switzerland, Japan and Germany.
Help employers find you! Check out all the jobs and post your resume.
PHILADELPHIA – June 15, 2015 ––ERT, a leading global provider of high-quality patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions, today announced a number of product updates it will demonstrate at the Drug Information Association (DIA) Annual Meeting in Washington, DC June 14-17, 2015.
DIA Annual Meeting attendees can visit ERT’s Innovation Lab booth #2000 and expanded booth #2025 for live, interactive demonstrations of advancements to its line of eClinical trial solutions, including:
• Wireless ECG / eCOA Tablet Integration: Integrating ECG data wirelessly with electronic clinical outcome assessment (eCOA) data reduces site burden while increasing data integrity. ERT will demonstrate how this advanced wireless solution reduces investigator site burden and improves clinical data quality.
• ERT Insights Cloud™: A first-in-class solution, ERT’s agile and adaptive Insights Cloud delivers unparalleled visibility and control across all of the disparate systems and diverse teams involved in global clinical trials, providing end-to-end visibility across data sources and putting clinical trial intelligence at the sponsor’s fingertips.
• Site Selection Analytics: This latest addition to the ERT Insights Cloud delivers data on over 40,000 sites and millions of trial endpoints to provide sponsors and CROs with an industry-unique set of data to complement their investigative site evaluation process.
• MasterScope 2: ERT’s comprehensive, diagnostic platform for spirometry, ECG, and home monitoring meets the data collection and processing needs of worldwide clinical trial sponsors in the development of medical treatments for respiratory conditions.
•Wireless Biosensor / eCOA System Integration: ERT will demonstrate a proof of concept integration of near real-time, continuous, clinical-grade biometric measurements captured on a wearable patch biosensor into ERT’s eCOA System.
•Patient Connect Engagement App: See a demonstration of how ERT helps sponsors retain patients by providing education, plain language, visit information, and shared data and allows patient to connect with the site and share information with family members.
• Rater Training: Learn how Rater Training is used within clinical trials to improve the consistency of subjective data collected from interviewers – and has been proven to reduce rater errors and standardize scale administration.
• eCOA App – Get hands on experience and demo the leading eCOA app on various smartphone and tablets including a mega Smartphone pad.
Information on these and many other novel product developments that will be showcased during the DIA Annual meeting can be found at http://www.ert.com/dia-annual-meeting/. “DIA Annual Meeting attendees will not want to miss the exciting developments being presented this week,” said Scott Dixon, Vice President, Marketing and Corporate Strategy at ERT. “By continually advancing our line of eClinical trial solutions, ERT is truly innovating better health and helping pharmaceutical companies and CROs meet their clinical objectives more efficiently and reliably not only today, but looking toward the trial of the future.”
For more information, visit http://ert.com/dia-annual-meeting/.
About ERT
ERT (http://www.ert.com) is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the efficiency of the clinical development process throughout the product lifecycle. ERT delivers the most widely deployed solutions in centralized Cardiac Safety, Respiratory, Suicide Risk Assessment, electronic Clinical Outcome Assessments (eCOA) – which includes patient-, clinician-, observer- and performance-reported outcomes – and cloud-based analytics and performance metrics. By efficiently integrating these solutions through a system built upon a scientific and regulatory foundation, ERT collects, analyzes and delivers safety and efficacy data critical to the approval, labeling and reimbursement of pharmaceutical products. ERT is a global organization with headquarters in Philadelphia, PA and offices throughout the U.S., U.K., Switzerland, Japan and Germany.
Help employers find you! Check out all the jobs and post your resume.